Instead of forcing your body into extremes, these treatments work with your biology to regulate appetite, improve insulin response, and support sustainable fat loss over time
En los ltimos aos, la aparicin de tratamientos farmacolgicos altamente eficaces basados en hormonas gastrointestinales, especialmente los agonistas del receptor GLP-1 (arGLP-1) y los agonistas duales GIP/GLP-1, ha supuesto un cambio de paradigma en el manejo de los pacientes con obesidad, permitiendo alcanzar prdidas de peso superiores al 20 % en algunos pacientes, controlar las complicaciones relacionadas con la adiposidad, mejorar la capacidad funcional y la calidad de vida
If approved, Orforglipron will initially be available as a brand-name drug only
The Novel GIP, GLP-1 and Glucagon Receptor Agonist Retatrutide for the Treatment of Type 2 Diabetes: A Short Review on Potential Mechanisms and Clinical Evidence
Always choose products with minimal added sugars and artificial additives, and discuss supplementation with your clinical team if you have kidney disease or any other relevant health condition